SCHEMBL1013680

SCHEMBL1013680

COc1ccc(-c2ccc3c(n2)CCN(CC(=O)N2CCN4C(C)CCCC4C2)C3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
TSHR P16473 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 2/20 0.36
HTT P42858 2/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
RAB9A P51151 2/20 0.36
MAPK1 P28482 1/20 0.36
ITK Q08881 1/20 0.36
KMT2A Q03164 3/20 0.36
HSD17B10 Q99714 2/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12707155 1.00 ALDH1A1 (0.39) ALDH1A1TSHRKDM4EHPGDGAA
SCHEMBL12707147 0.87 CHRM2 (0.34) ALDH1A1TSHRGAAHTTMAPT
SCHEMBL1017308 0.87 CHRM2 (0.34) ALDH1A1TSHRGAAHTTMAPT
SCHEMBL1017466 0.83 ALDH1A1 (0.34) ALDH1A1GAARAB9AHSD17B10NPC1
SCHEMBL12707139 0.83 ALDH1A1 (0.34) ALDH1A1GAARAB9AHSD17B10NPC1
SCHEMBL12707161 0.79 ADRA1A (0.38) ALDH1A1KMT2A
SCHEMBL1018115 0.79 ADRA1A (0.38) ALDH1A1KMT2A
SCHEMBL12707157 0.79 ADRA1A (0.36) ALDH1A1KDM4EGAAKMT2ACASP1
SCHEMBL1018562 0.79 ADRA1A (0.36) ALDH1A1KDM4EGAAKMT2ACASP1
SCHEMBL12707159 0.77 ADRA1A (0.36) ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES LIGAND PHARMACEUTICALS, INC. (US) 2011-04-07 US disclosed
EP-1998620-B1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES NEUROGEN CORP (US) 2011-01-12 EP disclosed
US-7795262-B2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION (US) 2010-09-14 US disclosed
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues NEUROGEN CORPORATION 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232591-A1 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues HRH3, HRH4, HRH1 ALDH1A1 1229/4885TSHR 314/4885KDM4E 2634/4885
US-20110082130-A1 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 ALDH1A1 1229/4885TSHR 314/4885KDM4E 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.